COLL vs PLTR · P/E 17, rev $181.9M vs P/E 584, rev $4.48B
Collegium Pharmaceutical Inc (COLL) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the COLL and PLTR stock pages for the full models.
Not investment advice.